Target intelligence / Profile preview

Diaphragmatic contractility

Molecular classification
Other (physiological property; not a molecule or receptor)
01

Overview

Diaphragmatic contractility" refers to the ability of the **diaphragm muscle**—the primary muscle of respiration—to generate force and facilitate breathing by contracting and relaxing. The diaphragm is a dome-shaped skeletal muscle that separates the thoracic cavity from the abdominal cavity. Its contraction increases thoracic volume and decreases intrathoracic pressure, allowing air to enter the lungs during inhalation; relaxation leads to exhalation[1][3][5][7]. The diaphragm's function depends on intact innervation by the phrenic nerve. Impaired diaphragmatic contractility can result from various conditions such as mechanical ventilation-induced atrophy or chronic heart failure-associated myopathy[4][6]. While "diaphragmatic contractility" is critical for life-sustaining respiration and has clinical significance in disease states affecting breathing capacity, it is not itself a molecular target but rather an emergent property resulting from coordinated action at cellular (sarcomere), tissue, neural, and systemic levels[2][4]. **Note:** This entry does *not* correspond to a specific molecule/receptor/enzyme/transporter but rather describes a physiological function/property. Therefore, - It should not be considered a canonical therapeutic target. - There are no direct interacting drugs or mechanisms of action specific for "diaphragmatic contractility," though some interventions may modulate it indirectly through other targets. If you are seeking information about molecules that regulate diaphragmatic contraction—such as acetylcholine receptors at neuromuscular junctions or ryanodine receptors involved in calcium signaling—please specify those targets for structured data extraction.

Other names
Diaphragm muscle contractionContractile function of the diaphragmDiaphragm strengthDiaphragm force generation
02

Biological functions

Respiration (inhalation and exhalation)Generation of negative intrathoracic pressureExpulsion functions (vomiting, defecation, urination)
03

Disease associations

Respiratory failureChronic heart failure-related respiratory dysfunctionVentilator-induced diaphragmatic dysfunction
04

Safety considerations

Risk of respiratory failure if contractility is impaired[1]
05

Biomarkers

Diaphragm thickness on imaging as a prognostic marker in sepsis and COVID-19[1]

Beyond the preview

Go deeper on Diaphragmatic contractility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diaphragmatic contractility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call